•
Mar 31, 2022

Stoke Therapeutics Q1 2022 Earnings Report

Total Revenue
$3M
EPS
-$0.66
Previous year: -$0.46
+43.5%
Gross Profit
$2.38M
Cash and Equivalents
$84.1M
Free Cash Flow
$31.7M
Total Assets
$316M

Stoke Therapeutics

Stoke Therapeutics